GENERAL ANNOUNCEMENTS

December 2, 2005
New Recommendations on handling EPREX
The purpose of this document is to provide recommendations for the handling of EPREXÒ by health care professionals in pharmacies, hospitals and satellite/outpatient centers. Before administration of EPREXÒ it is important to always consult the prescribing information provided with the product.

June 17, 2005
Cancer Patients Corner
FELIX, 42 ,a burly car mechanic recently diagnosed to have lung cancer, stared at the half-empty pail of water in front of him for almost twenty minutes.

June 16, 2005
Number of Anemia Cases Linked To J&J's Eprex Drug Falls 80%
This NEJM original article was covered by The Wall Street Journal, NY Times, Bloomberg, HealthDayNews, Reuters Health

June 16, 2005
lethal anemia
Similar conclusions about potentially lethal anemia reached independently by MUHC scientists and U.S. researchers

June 16, 2005
Millennium Files Supplemental
Millennium Files Supplemental New Drug Application for VELCADE(R) (Bortezomib) for Injection for the Treatment of Patients with Second-Line Multiple Myeloma

September 29, 2004
War Against Cancer Turning to 'Smart' Weapons
The war on cancer in the 21st century is becoming one of guerrilla tactics rather than saturation bombing, with "molecularly targeted" drugs replacing wholesale chemotherapy in many cases.

September 29, 2004
One woman's journey with ovarian cancer
To get women and medical professionals to pay more attention to ovarian cancer, JAMA recently published a report pinpointing three core symptoms:

September 29, 2004
Breathing disorder linked with blood-related hormone
As reported in the American Journal of Hypertension, levels of erythropoietin appear to be increased in patients with severe obstructive sleep apnea (OSA)

September 29, 2004
Bayer and Onyx Announce Phase II Results
This press release was issued by Bayer and covered by BioCentury, BioWorld, Bloomberg, The Pink Sheet Daily, Reuters